Carcinoma Breast Articles & Analysis: Older
4 articles found
However, Merck's bispecific ADC pipeline M1231 also targets EGFR/MUC1, which is co-expressed in a variety of tumor cells, including non-small cell lung cancer (NSCLC), esophageal squamous cell carcinoma (ESCC), head and neck squamous cell carcinoma cell carcinoma, triple-negative breast cancer, and ovarian cancer, among others. ...
Currently, ADC has played a significant role in the treatment of some malignant tumors, such as trastuzumab in the treatment of breast cancer, but its application in the treatment of prostate cancer (PCa) progress slowly. ...
Clinical Context 65-year-old female with invasive lobular carcinoma of the breast with skeletal carcinomatosis. After years of progression-free survival, a PET-CT scan detected several novel, abnormal metabolic bone lesions. ...
Quantitative output variables HER2/neu gene status has become indispensable in pathologic scoring of invasive ductal breast carcinoma. Although FISH is an expensive and time consuming process, it guarantees the result of the case. ...